申请人:ABBOTT LAB
公开号:WO2005019191A2
公开(公告)日:2005-03-03
Compounds having the formula (I), wherein B is (a), (b), (c), or (d); A is a monocyclic or bicyclic ring selected from the group consisting of aryl, cycloalkyl, cycloalkenyl, heteroaryl and heterocycle (the other substituents are defined in the claims), are hepatitis C (HCV) polymerase inhibitors. Also disclosed are a composition processes for making the compounds, and synthetic intermediates employed in the processes.